Tag: Jonathan Parr

The American Society of Tropical Medicine and Hygiene’s (ASTMH) Annual Meeting, Nov. 9-13 in Toronto, Ontario, Canada, drew approximately 4,900 global health professionals from around the world. Investigators from the IDEEL Lab contributed new insights to the global conversation, drawing attention to a defining crossroads in East Africa’s malaria response....

CHAPEL HILL, NC — (November 24, 2025) A multi-disciplinary team of researchers led by Jonathan Parr, MD, MPH, at UNC Chapel Hill’s Institute for Global Health and Infectious Diseases, with partners at North Carolina State University, Emory University, Accelint’s SoarTech, and a network of international collaborators has received  $2.2 million...

This year’s ID Week will take place October 19-22, 2025, in Atlanta, GA. ID Week is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists....

Brian Bramson, MD, and Jonathan Parr, MD, MPH, have been named Fellows by the Infectious Diseases Society of America. Fellowship in IDSA is one of the highest honors in the field of infectious diseases, recognizing distinguished clinicians and scientists in the U.S. and around the world. Dr. Bramson cares for...

Jonathan Parr, MD, MPH, associate professor of medicine in the division of infectious diseases and member of the UNC Institute for Global Health and Infectious Diseases, has been selected to serve as a National Academy of Medicine (NAM) Emerging Leaders in Health and Medicine (ELHM) Scholar for a three-year term...

Malaria rapid diagnostic tests (mRDTs) that detect histidine-rich protein 2 (HRP2) remain the mainstay of falciparum malaria diagnosis in Sub-Saharan Africa. Understanding their test characteristics when used for surveillance in asymptomatic populations is important. Jonathan Juliano, MD, MSPH, Jonathan B. Parr, MD, MPH, Jessica Lin, MD, MSCR, explored the rate of...

Fabien Vulu, MD, PhD, is a postdoctoral researcher from the Democratic Republic of the Congo (DRC) specializing in mosquito vectors of malaria parasites and viruses. He joined the IDEEL Lab at the Institute for Global Health and Infectious Diseases to study under the mentorship of Dr. Jonathan Parr, MD, MPH, training in malaria parasite sequencing for the PaluSeq...

(Following is a look back at the 3rd Annual Global Health Scholars Symposium. Links to recordings are provided throughout.)   Myron Cohen, MD, director of the Institute for Global Health and Infectious Diseases welcomed faculty, students and fellows to the 3rd Annual Global Health Scholars Symposium Friday, Feb. 14, recognizing...

The Office of Fellowships and Training at the UNC Institute for Global Health and Infectious Diseases ensures educational and mentored research training and field experience for eligible masters, doctoral or post-doctoral candidates. Managed by Kristin Reed, MPH; Marla Allen, MPH; Dzidzai Muyengwa, MPH; and Benjamin Chi, MD, MSc, following is...

Syphilis vaccine development remains a high priority with a rising number of congenital syphilis cases worldwide. Unfortunately, vaccine development is still in a pre-clinical phase, and ongoing translational work is needed to identify vaccine candidates targeting highly conserved surface-exposed antigens expressed by geographically diverse strains of Treponema pallidum (TPA). But...

With data from one of the most extensive genomic surveys of the syphilis bacterium – correlated with clinical information from patients – an international team of researchers and doctors are on the hunt for proteins on the surface of the microbe that don’t vary and could be good targets for...

April is sexually transmitted infections (STI) awareness month, and Arlene Seña, MD, MPH, a researcher with the Institute for Global Health and Infectious Diseases, is sounding the alarm about the importance of syphilis prevention, testing, and treatment. U.S. syphilis cases have increased nearly 80% since 2018,  a level not seen...